日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語(yǔ)Fran?ais
China
Home / China / National affairs

Judicial accuracy spotlighted as court revises 'Breaking Bad' drug case rulings

By Cao Yin | chinadaily.com.cn | Updated: 2025-01-23 23:27
Share
Share - WeChat

A Chinese court's decision to revise the ruling in a drug case involving a former associate chemistry professor — dubbed the "Chinese version of Breaking Bad" — reflects the country's commitment to enforcing the law accurately and demonstrating a strong stance against drug crimes, a senior prosecutor said.

Hu Yaoxian, a prosecutor from the Supreme People's Procuratorate, China's top prosecuting body, made the remarks after the Hubei High People's Court overturned its previous judgment against a group of former chemistry professionals.

According to a statement released Thursday by the China National Narcotic Control Committee, the high court issued a new ruling in December after a retrial, finding Yang Zhaohui, Zhang Zhengbo, Bao Junxi, and Feng Jing guilty of smuggling, selling, transporting, and manufacturing drugs.

The court resentenced Yang and Zhang to life imprisonment and 15 years in prison, respectively, and upheld earlier sentences of eight years each for Bao and Feng.

In May 2023, the same court had sentenced Yang and Zhang to 13 years and 11 years in prison, respectively, but at the time, all four were convicted of illegal business operations, the committee said.

Prosecutors in Hubei challenged the ruling, arguing that the convictions and sentences were legally flawed and too lenient. In September 2023, they sought a review from the Supreme People's Procuratorate, according to JCRB.com, a news outlet under the procuratorate.

Hu emphasized that Chinese law explicitly defines drugs as narcotic and psychotropic substances regulated by the state that can cause addiction. He noted that the substances produced and sold by the four defendants were under state control and classified as drugs.

"The revised ruling aligns with the law," Hu said, adding that the changes in conviction and sentencing serve to rehabilitate the defendants, educate them on the societal harm caused by their actions, and deter future offenses.

He said the case sends a broader warning to the public that no one can illegally handle narcotic or psychotropic substances controlled by the state, reinforcing the principle of legal compliance.

"The prompt correction of the earlier flawed judgment highlights the accurate implementation of the law and underscores the nation's strict judicial policy on drug crimes," Hu said.

Chinese media previously reported that Zhang, a former associate chemistry professor at Huazhong University of Science and Technology in Wuhan, was a leading manufacturer of new psychoactive substances.

This case is a significant typical case of crimes involving new psychoactive substances in China. The defendant, Zhang Zhengbo, due to his special status as an associate professor, has been hyped as the "Chinese version of Breaking Bad," attracting widespread public attention.

Zhang and Yang, a former classmate, established a chemical company registered as a producer of pharmaceutical intermediates. However, they manufactured methcathinone and sold it in the United States and Europe disguised as ordinary chemical products.

The committee said Zhang and his employees were apprehended in June 2015. Investigators found that between January 2014 and June 2015, Zhang, Yang, Bao, and Feng produced and sold more than 110 kilograms of psychotropic drugs under state control.

In March 2017, the Wuhan Intermediate People's Court convicted the four of smuggling, selling, transporting, and producing drugs. Yang was sentenced to death with a two-year reprieve, Zhang received life imprisonment, and Bao and Feng were each sentenced to 15 years in prison.

The defendants appealed, and in April 2018, the high court sent the case back to the Wuhan court for retrial.

In June 2019, their sentences were reduced, but the original convictions were upheld. The latest ruling in December marks a significant legal correction in a high-profile case.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 欧美日韩综合视频 | 欧美精品99 | 男女做www免费高清视频 | 亚洲情av| 日韩av在线不卡 | 天天拍天天操 | 性做久久久久免费看 | 国产品久久 | 色男人综合| 久久久久久免费播放一级毛片 | 国产欧美日韩在线不卡第一页 | 2022国产成人福利精品视频 | 欧美久在线观看在线观看 | 天天干天天操天天透 | 成人午夜性视频欧美成人 | 综合久久亚洲 | 国产免费中文字幕 | 九九热在线视频免费观看 | 中文字幕一区二区三区四区 | 欧美1区2区3区 | 久久综合欧美 | 天天干天天操天天爽 | 日本黄色网战 | 男女污污无遮挡免费观看 | 91精品国产综合久久久久久 | 色婷婷社区 | 精品视频在线播放 | 欧美高清在线精品一区二区不卡 | 一区二区三区 日韩 | 天天插天天 | 色综合精品久久久久久久 | 天天更新天天久久久更新影院 | 亚洲精品一区在线观看 | aaa一级毛片免费 | 国产精品国色综合久久 | 99久久免费中文字幕精品 | 色妞色视频一区二区三区四区 | 欧美三极 | 91久久久久久久一区二区 | 亚洲专区在线 | 美国一级毛片片aaa 香蕉视频在线观看免费 |